11 Best Long Term Low Risk Stocks to Invest in

7. Haemonetics Corporation (NYSE:HAE)

EPS next 5Y: 11.12%

Beta: 0.40

Haemonetics Corporation (NYSE:HAE) is included in our list of 11 best long term low risk stocks to buy. The company’s stocks are upgraded to Buy despite a 9% decline in revenue, reported in the Q4 earnings call.

Headquartered in Massachusetts, Haemonetics Corporation (NYSE:HAE) is engaged in the development and supply of innovative medical technologies and systems for blood and plasma collection, surgical cell salvage, and hospital transfusion services. The company has a global reach with business operations in more than 50 countries. Its integrated solutions help improve procedural efficiency and patient care within leading hospitals.

On May 8, 2025, Haemonetics Corporation (NYSE:HAE) released its Q4 2025 earnings report, which highlighted a 9% decline in revenue for the quarter and a 6% decline in fiscal 2025 due to the planned CSL transition. The revenue from the Blood Center in particular went down by 22%, while it is anticipated to decline by 23 to 26% in fiscal 2026 due to portfolio streaming.

Following these results, Citi maintained a Hold rating on the stock with a price target of $71 on May 22, 2025. Later, on July 9, 2025, the company upgraded the stock from Hold to Buy rating and raised the price target to $90, reflecting faith in the company’s growth potential.

Haemonetics (NYSE:HAE) offers strong stability with a low beta of 0.40 and promising growth potential, projecting an 11.12% EPS increase over the next five years.